USA Technologies to Present at the Roth Capital Partners 19th Annual OC Stock Conference
Roth Capital Partners Stock Conferences are one of the largest in the nation for micro and small-cap companies in the Technology, Healthcare, Financial Services, and Consumer Products sectors. For more information on the conference, please visit the conference website at http://rothconference.com, or call the conference desk at 800-678-9147.
Since 1984, Roth Capital Partners has been a leader and innovator in the small and micro cap markets. With headquarters in Newport Beach, California and offices in strategic locations in the Western United States, Roth Capital Partners is a full service investment bank serving corporate and institutional clients throughout the world. Roth offers a wide array of investment banking services including: initial public offerings, follow-ons, PIPEs, private placements, mergers and acquisitions, investment research, and institutional sales and trading. The firm is perhaps best known for finding, funding and fostering the growth of emerging companies. Over the last ten years, Roth has raised more than $8.7 billion for small and micro cap public companies and completed more than 123 merger, acquisition and advisory assignments. It is a member of the National Association of Securities Dealers (NASD), and the Securities Investor Protection Corporation (SIPC). For more information, visit www.rothcp.com.
With the exception of the historical information contained in this release, the matters described herein contain forward-looking statements that involve risk and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product acceptance, the ability to continually obtained increased orders of its products, the ability to meet installation goals, economic, competitive, governmental impacts, whether its pending patents will be granted or defendable; validity of intellectual property and patents of USA, the ability of USA to license its patents, the ability of USA to commercialize its developmental products, technological and/or other factors, which could cause actual results or revenues to differ materially from those contemplated by these statements.